MedPath

OCT Angiography in Wet AMD

Recruiting
Conditions
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Registration Number
NCT02253030
Lead Sponsor
Oregon Health and Science University
Brief Summary

The primary goals of this study are to use optical coherence tomography (OCT) angiography (blood vessel mapping) to:

1. diagnose the presence of new blood vessels in wet age-related macular degeneration (AMD)

2. evaluate patients undergoing treatment for wet AMD

3. determine if reduced flow to the choroid is a risk factor for developing wet AMD.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measure of drusen area in mm23 years
Measure of CNV membrane area in mm21 year
Measure of choroidal neovascular (CNV) vessel area in mm21 year
Measure of CNV length density in mm1 year
Measure of retinal fluid volume in mm31 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Casey Eye Institute, Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Casey Eye Institute, Oregon Health & Science University
🇺🇸Portland, Oregon, United States
George Pacheco, COA
Contact
503-494-7398
pachecge@ohsu.edu
Denny Romfh, OD
Contact
503-494-4351
romfhd@ohsu.edu
Christina Flaxel, MD
Sub Investigator
Thomas Hwang, MD
Sub Investigator
Michael Klein, MD
Sub Investigator
Phoebe Lin, MD, PhD
Sub Investigator
Andreas Lauer, MD
Sub Investigator
Kavita Bhavsar, MD
Sub Investigator
John Campbell, MD, PhD
Sub Investigator
Yali Jia, PhD
Sub Investigator
Ou Tan, PhD
Sub Investigator
© Copyright 2025. All Rights Reserved by MedPath